INC
Incanthera plc
Access
ISIN
GB00BGL7YW15
Bid
6.40
Mid
6.55
Ask
6.70
Key Information
- Price Change
- 0.00%
- Year High
- 6.95
- Year Low
- 6.55
- Last Trade
- 17 May 23
- Market Cap
- £5.07M
- Par
- 0.02
- Bid
- 6.40
- Mid Price
- 6.55
- Ask
- 6.70
- Instrument Type
- Ordinary Shares
- MIFID Status
- MTF
- Tradable Securities
- 77.46M
- Sector
- Healthcare
Prices in GBX except for Market Cap in GBP
About Incanthera plc
The Company is a specialist oncology company focused on transforming cancer treatment by creating environments in which cancer cannot survive. It seeks to identify and develop innovative solutions to current clinical, commercially relevant unmet needs, utilising new technology from leading academic institutions. The Company’s current lead product and focus is Sol, a potentially innovative topical product for the treatment of solar keratosis and the prevention of skin cancers. This has achieved proof of concept and is currently being prepared for licensing to a commercial partner within 12-18 months. The Company originated from the Institute of Cancer Therapeutics – University of Bradford and, in addition to Sol, has acquired and developed a portfolio of specific cancer-targeting therapeutics through a pipeline agreement with the Institute of Cancer Therapeutics and other corporate acquisitions. Incanthera’s strategy is to develop each candidate in the portfolio from initial acquisition or discovery to securing its future through commercially valuable partnerships at the earliest opportunity in its development pathway.<p>
Latest Trades
Date | Volume | Price (GBX) | Value (GBP) |
---|---|---|---|
17 May 23 09:12 | 769 | 6.40 | 49.22 |
21 Apr 23 09:28 | 33,300 | 6.50 | 2,164.50 |
21 Apr 23 09:28 | 33,300 | 6.40 | 2,131.20 |
27 Mar 23 12:06 | 210 | 6.40 | 13.44 |
22 Mar 23 10:19 | 6,000 | 6.40 | 384.00 |
Latest Announcements
Date | Title |
---|---|
05 Apr 23 12:04 | Incanthera PLC - Result of Warrant Holder Meeting |
30 Mar 23 07:00 | Incanthera PLC - Further re: Director's Dealing |
13 Mar 23 07:00 | Incanthera PLC - Director’s Dealing and Proposed Warrant Extension |
07 Dec 22 07:00 | Incanthera PLC - Half-year Report |
27 Sep 22 12:58 | Incanthera PLC - Result of AGM |
Financial Information
GBP | Latest Results 2021-03-31 |
---|---|
EnterpriseValue | £11 |
EV / EBITDA | -11.15 |
EV / EBIT | -11.15 |
PE Ratio | -12.52 |
PE Ratio Growth | 158.54% |
Dividend Yield | 0 |
Free Cash Yield | -6.88% |
Address
Registered Address
76 King Street, Manchester, M2 4NH, United Kingdomsuzanne.brocks@incanthera.com
Phone
+44 (0) 161 817 5005
Contacts
Corporate Adviser
Cairn Financial Advisers LLP., 9th Floor, 107 Cheapside, London, EC2V 6DN, United KingdomRegistrar
Neville Registrars Limited , Neville House,Steelpark Road, Halesowen, West Midlands, B62 8HD, United Kingdom